14 September 2022
Viruses | Top Cited Papers in 2021
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)”
by Johannes Korth et al.
Viruses 2021, 13(5), 756; https://doi.org/10.3390/v13050756
Available online: https://www.mdpi.com/1999-4915/13/5/756
Cited by 92 | Viewed by 2845
2. “Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design”
by Xuhua Xia
Viruses 2021, 13(1), 109; https://doi.org/10.3390/v13010109
Available online: https://www.mdpi.com/1999-4915/13/1/109
Cited by 91 | Viewed by 16009
3. “Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice”
by Pratima Kumari et al.
Viruses 2021, 13(1), 132; https://doi.org/10.3390/v13010132
Available online: https://www.mdpi.com/1999-4915/13/1/132
Cited by 82 | Viewed by 30382
4. “Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection”
by Federico Gobbi et al.
Viruses 2021, 13(3), 422; https://doi.org/10.3390/v13030422
Available online: https://www.mdpi.com/1999-4915/13/3/422
Cited by 80 | Viewed by 12495
5. “Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?”
by Ivana Lazarevic et al.
Viruses 2021, 13(7), 1192; https://doi.org/10.3390/v13071192
Available online: https://www.mdpi.com/1999-4915/13/7/1192
Cited by 79 | Viewed by 8279
6. “A Roadmap for Genome-Based Phage Taxonomy”
by Dann Turner et al.
Viruses 2021, 13(3), 506; https://doi.org/10.3390/v13030506
Available online: https://www.mdpi.com/1999-4915/13/3/506
Cited by 75 | Viewed by 5498
7. “Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy”
by Francesco Di Gennaro et al.
Viruses 2021, 13(3), 371; https://doi.org/10.3390/v13030371
Available online: https://www.mdpi.com/1999-4915/13/3/371
Cited by 72 | Viewed by 3020
8. “Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms”
by Bruno Silva Andrade et al.
Viruses 2021, 13(4), 700; https://doi.org/10.3390/v13040700
Available online: https://www.mdpi.com/1999-4915/13/4/700
Cited by 69 | Viewed by 12025
9. “Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications”
by Jasdeep Singh et al.
Viruses 2021, 13(3), 439; https://doi.org/10.3390/v13030439
Available online: https://www.mdpi.com/1999-4915/13/3/439
Cited by 65 | Viewed by 5564
10. “Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease”
by Lukas van de Sand et al.
Viruses 2021, 13(4), 609; https://doi.org/10.3390/v13040609
Available online: https://www.mdpi.com/1999-4915/13/4/609
Cited by 59 | Viewed by 4984